🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎥In this interview, Valeria Paradies and Chiara De Biase discuss the new expert consensus document on sex-specific risks, tailored antithrombotic strategies, and improving female representation in ACS trials published in EuroIntervention with the #EAPCI and the European Society of Cardiology working group

Congratulations Prof Duk-Woo Park !!! It is one of the most talk about study. This award prove that. Bravo! EuroIntervention PCRonline 🫀 #EuroPCR MIЯVΛƬ #IC Erik Rafflenbeul Indah Sukmawati, MD Alessandro Beneduce Guillaume Bonnet Hany Ragy Dr Iain Gillingham Carlos Luqueño Mi Chen 陈密

We are almost at the end of #EuroPCR but there is still Friday to come - enjoy your evening and see you tomorrow!

AsiaIntervention held its 2025 Strategic Board Meeting at EuroPCR in Paris with Editor-in-Chief Upendra Kaul and Deputy Editors. Grateful for their inspiring leadership. #EuroPCR #interventionalcardiology

#EuroPCR - PCR Perspectives: How to implement the diagnosis of #INOCA in everyday practice 📺pcronline.com/Cases-resource… Professor Vijay Kunadian and Javier Escaned explore the real-world implementation of INOCA (#Ischemia with Non-Obstructive Coronary Arteries) and #ANOCA (Angina with

It was a great pleasure being part of this outstanding event. Looking forward to next year’s #TCTPlusMiddleEast2026 Cardiovascular Research Foundation TCTME+ Mark your 🗓️ Karim Al-Azizi, MD MIЯVΛƬ #IC Wail AlkashkariFSCAI,FPICSوائل القشقرى🇸🇦🇨🇦🇺🇲 Khaled AlShaibi Juan F. Granada Mamas A. Mamas David J. Cohen, MD, MSc Cardiovascular Research Foundation Anas T. Noman Musa A. Sharkawi

🚀 Steerable microcatheter aids complex CTO PCI in LCx with severe tortuosity. Game-changer for tough anatomies! 💡🫀 🔗 Full study: asiaintervention.org/article/recana… #PCI #CTO #Cardiology #Innovation #MedicalDevices #Intervention

My learning points from #euroPCR 2025: #IC community interests are high in the coronary field despite growing of the structural field. Topics which surprised me in terms of assistance are vulnerable plaque, coronary thrombectomy, imaging, physiology and CHIP.this reflects the

PCR Perspectives: how to manage treatment dilemmas in #STEMI patients with multivessel disease 📺pcronline.com/Cases-resource… Managing STEMI patients with MVD is a complex challenge evolving rapidly thanks to new clinical evidence. Angela McInerney , Natalia Pinilla, and Matthias Götberg

61-year-old with recurrent stent blockage treated with #cuttingballoons and #drugelutingtech. #OCT showed success—and paclitaxel crystals. Symptom-free at 4 months! 💉🫀📈 #InterventionalCardiology Read the full article on AsiaIntervention: asiaintervention.org/article/paclit…

At #EuroPCR, I sat down with EuroIntervention EIC Davide Capodanno for TCTMD's #OnRecord to chat about what it means to leave a legacy in cardiovascular medicine. tctmd.com/videos/on-reco…

80F with LMT/LAD blockage had #PCI. #OCT showed a Z-shaped catheter risking fracture. Using the newer #Opstardevice avoided this. Device design is crucial in #patientsafety. Read more here: asiaintervention.org/article/optica… @APSIC EuroIntervention PCRonline 🫀

🚨 A new heart valve system just passed its first human test! The Crea Valve showed strong results with no major complications. A big step forward for heart care! 🫀 #HeartHealth #MEDTECH @APSIC EuroIntervention PCRonline 🫀 Read more: asiaintervention.org/article/initia…

#ICI myocarditis, could we rechallenge?🫀 ⚠️#Multidisciplinary team discussion is 🔑key before deciding on rechallenge 🆚 permanent discontinuation Considerations include: 📍Clinical presentation: is it fulminant, non-fulminant, or asymptomatic? 📍Alternative cancer treatments

Even #BASILICA can’t always prevent coronary occlusion during #TAVI—especially with valve misalignment. A must-read case for structural heart teams. 🫀 👉 asiaintervention.org/article/commis… @APSIC EuroIntervention PCRonline 🫀

Next-day discharge after alternative access #TAVI? In this prospective study of 85 A-TAVI patients, NDD/48h discharge was safe with low 30-day readmission and zero mortality. Transapical access required longer stay, but ~50% discharged by day 2. Rodrigo Bagur 🇦🇷🇨🇦

First #Cardiovalve tricuspid valve replacement in Asia! 🫀 A game-changer for high-risk #heartfailure patients. 👉 asiaintervention.org/article/transc… @APSIC EuroIntervention PCRonline 🫀

Successful #percutaneousclosure of a perimembranous ventricular septal defect (pmVSD) in a 2-month-old infant using the #AmplatzerDuctOccluderII device. #PediatricCardiology 👉asiaintervention.org/article/percut… @APSIC EuroIntervention PCRonline 🫀

🚨 3-yr data: BioMime Morph SES shows 98.8% TLF-free survival, 0.24% ST, 0.5% mortality in very long lesions (50–60 mm). No overlaps. No IVUS. Strong real-world outcomes. 📄asiaintervention.org/article/long-t… @APSIC EuroIntervention PCRonline 🫀

Promising results with #MeRes100 bioresorbable scaffold: 98.84% success, 0% thrombosis, MI, or TLR at 12 months. A metal-free future for PCI? 📖asiaintervention.org/article/a-real… @APSIC EuroIntervention PCRonline 🫀